Ikris Pharma International supply innovator drugs/comparator drugs/ RLD for bioequivalence study/ clinical trials from the U.S, EU, UK, Australia, Canada, Brazil, Japan and other countries worldwide.
Ikris Pharma International (IPI) facilitates patients in accessing medicines and other pharmaceutical products unavailable in their home country against valid prescriptions in conformity with all local laws and regulations. IPI does not facilitate access of narcotics, sedatives or any other substances prohibited by the local laws.
Ikris Pharma International do not manufacture any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by our suppliers are owned by their respective manufacturers or licensees.